focus -WSS

focus

author：knowledge 2025-10-02 18:05:18 - browse：2186

Adobe

The Food and Drug Administration is expected to approve Merck’s drug to treat a rare lung disorder called pulmonary arterial hypertension on Tuesday, making available a novel treatment for a deadly condition that’s long been challenging to treat.

In a large trial published last year, the drug, called sotatercept, exceeded expectations in significantly increasing the distance that patients could walk and cutting the risk that their condition would worsen, that they would die, and that they would need new treatments.

Pulmonary arterial hypertension, or PAH, is estimated to occur in 15 to 50 per million people, mostly in women. It’s characterized by a proliferation of cells in the blood vessels that connect the right side of heart to the lungs, making it harder for blood to pass through and leading the heart to have to work harder to pump blood into the lungs. The disease, which causes difficulty breathing, fatigue and dizziness, has a high mortality rate, with one study finding that one-fifth of patients died at around three years after diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Hospitals struggle to profit from CAR

hotspot

WSS

Study identifies new proteins linked to dementia risk 25 years later

DeSantis talks Trump, trans issues and 'what wokeness is'

Grail is spending more than ever lobbying Congress

Doctor appointment wait times are getting worse

New case study details death in closely watched Alzhiemer's trial

Stanford president faces new allegations over 1999 paper

explore

focus

entertainment

Virginia high school admissions case could be legal follow

Divers poised to search for children washed away in Pennsylvania flash flood

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Texas Department of Public Safety speaks out on migrant abuse allegations

The cancer drug shortage isn’t new — and neither are the solutions

Make 'food is medicine' a key part of White House nutrition meeting

United colonoscopy coverage change 'may cost lives,' doctors say

Did the public have the right to know Arthur Ashe had AIDS?

BioMarin wins approval for gene therapy to treat hemophilia A

PhRMA sues HHS over Medicare drug price negotiation

hotspot

Australia's humpback populations rebound raising hopes of marine scientists

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Judge rejects Trump's request to move Stormy Daniels hush

7 more heat

Listen: Biogen's messy board & Laronde's data problem

Pfizer's Covid pill remains 89% effective in final analysis, company says

Wikipedia

hotspot

explore

focus